Report Detail

Request for Sample of this report

Service & Software Global Intelligent Drug R-D Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4526580
    • |
  • 03 April, 2023
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Intelligent Drug R-D Services market size was valued at USD 1234.7 million in 2022 and is forecast to a readjusted size of USD 6715.1 million by 2029 with a CAGR of 27.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Leading biopharmaceutical companies believe in AI due to growing awareness in the pharmaceutical sector and rising investment in drug development. AI works with the latest advanced biology and chemistry processes to develop state-of-the-art algorithms; it has the potential to move drug screening from the bench to a virtual lab without the need for extensive experimental input and manpower.Most biopharmaceutical companies have started internal programs or are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets.
This report is a detailed and comprehensive analysis for global Intelligent Drug R-D Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intelligent Drug R-D Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Intelligent Drug R-D Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Intelligent Drug R-D Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Intelligent Drug R-D Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intelligent Drug R-D Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intelligent Drug R-D Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BenevolentAI, Exscientia, IBM, Alphabet and Berg Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Intelligent Drug R-D Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cloud Based
On-Premise
Market segment by Application
Drug Discovery Research
Drug Development Research
Clinical Research
Market segment by players, this report covers
BenevolentAI
Exscientia
IBM
Alphabet
Berg Health
Atomwise
Insitro
Cyclica
NVIDIA
Insilico Medicine
AstraZeneca
CAPGEMINI ENGINEERING
Hafnium Labs ApS
XtalPi Inc
Schrödinger
Charles River Laboratories
IQVIA Inc
Healx
Innoplexus
EVAXION BIOTECH A/S
Icometrix
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Intelligent Drug R-D Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intelligent Drug R-D Services, with revenue, gross margin and global market share of Intelligent Drug R-D Services from 2018 to 2023.
Chapter 3, the Intelligent Drug R-D Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Intelligent Drug R-D Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Intelligent Drug R-D Services.
Chapter 13, to describe Intelligent Drug R-D Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Intelligent Drug R-D Services
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Intelligent Drug R-D Services by Type
    • 1.3.1 Overview: Global Intelligent Drug R-D Services Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Intelligent Drug R-D Services Consumption Value Market Share by Type in 2022
    • 1.3.3 Cloud Based
    • 1.3.4 On-Premise
  • 1.4 Global Intelligent Drug R-D Services Market by Application
    • 1.4.1 Overview: Global Intelligent Drug R-D Services Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Drug Discovery Research
    • 1.4.3 Drug Development Research
    • 1.4.4 Clinical Research
  • 1.5 Global Intelligent Drug R-D Services Market Size & Forecast
  • 1.6 Global Intelligent Drug R-D Services Market Size and Forecast by Region
    • 1.6.1 Global Intelligent Drug R-D Services Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Intelligent Drug R-D Services Market Size by Region, (2018-2029)
    • 1.6.3 North America Intelligent Drug R-D Services Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Intelligent Drug R-D Services Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Intelligent Drug R-D Services Market Size and Prospect (2018-2029)
    • 1.6.6 South America Intelligent Drug R-D Services Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Intelligent Drug R-D Services Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 BenevolentAI
    • 2.1.1 BenevolentAI Details
    • 2.1.2 BenevolentAI Major Business
    • 2.1.3 BenevolentAI Intelligent Drug R-D Services Product and Solutions
    • 2.1.4 BenevolentAI Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 BenevolentAI Recent Developments and Future Plans
  • 2.2 Exscientia
    • 2.2.1 Exscientia Details
    • 2.2.2 Exscientia Major Business
    • 2.2.3 Exscientia Intelligent Drug R-D Services Product and Solutions
    • 2.2.4 Exscientia Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Exscientia Recent Developments and Future Plans
  • 2.3 IBM
    • 2.3.1 IBM Details
    • 2.3.2 IBM Major Business
    • 2.3.3 IBM Intelligent Drug R-D Services Product and Solutions
    • 2.3.4 IBM Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 IBM Recent Developments and Future Plans
  • 2.4 Alphabet
    • 2.4.1 Alphabet Details
    • 2.4.2 Alphabet Major Business
    • 2.4.3 Alphabet Intelligent Drug R-D Services Product and Solutions
    • 2.4.4 Alphabet Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Alphabet Recent Developments and Future Plans
  • 2.5 Berg Health
    • 2.5.1 Berg Health Details
    • 2.5.2 Berg Health Major Business
    • 2.5.3 Berg Health Intelligent Drug R-D Services Product and Solutions
    • 2.5.4 Berg Health Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Berg Health Recent Developments and Future Plans
  • 2.6 Atomwise
    • 2.6.1 Atomwise Details
    • 2.6.2 Atomwise Major Business
    • 2.6.3 Atomwise Intelligent Drug R-D Services Product and Solutions
    • 2.6.4 Atomwise Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Atomwise Recent Developments and Future Plans
  • 2.7 Insitro
    • 2.7.1 Insitro Details
    • 2.7.2 Insitro Major Business
    • 2.7.3 Insitro Intelligent Drug R-D Services Product and Solutions
    • 2.7.4 Insitro Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Insitro Recent Developments and Future Plans
  • 2.8 Cyclica
    • 2.8.1 Cyclica Details
    • 2.8.2 Cyclica Major Business
    • 2.8.3 Cyclica Intelligent Drug R-D Services Product and Solutions
    • 2.8.4 Cyclica Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Cyclica Recent Developments and Future Plans
  • 2.9 NVIDIA
    • 2.9.1 NVIDIA Details
    • 2.9.2 NVIDIA Major Business
    • 2.9.3 NVIDIA Intelligent Drug R-D Services Product and Solutions
    • 2.9.4 NVIDIA Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 NVIDIA Recent Developments and Future Plans
  • 2.10 Insilico Medicine
    • 2.10.1 Insilico Medicine Details
    • 2.10.2 Insilico Medicine Major Business
    • 2.10.3 Insilico Medicine Intelligent Drug R-D Services Product and Solutions
    • 2.10.4 Insilico Medicine Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Insilico Medicine Recent Developments and Future Plans
  • 2.11 AstraZeneca
    • 2.11.1 AstraZeneca Details
    • 2.11.2 AstraZeneca Major Business
    • 2.11.3 AstraZeneca Intelligent Drug R-D Services Product and Solutions
    • 2.11.4 AstraZeneca Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 AstraZeneca Recent Developments and Future Plans
  • 2.12 CAPGEMINI ENGINEERING
    • 2.12.1 CAPGEMINI ENGINEERING Details
    • 2.12.2 CAPGEMINI ENGINEERING Major Business
    • 2.12.3 CAPGEMINI ENGINEERING Intelligent Drug R-D Services Product and Solutions
    • 2.12.4 CAPGEMINI ENGINEERING Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 CAPGEMINI ENGINEERING Recent Developments and Future Plans
  • 2.13 Hafnium Labs ApS
    • 2.13.1 Hafnium Labs ApS Details
    • 2.13.2 Hafnium Labs ApS Major Business
    • 2.13.3 Hafnium Labs ApS Intelligent Drug R-D Services Product and Solutions
    • 2.13.4 Hafnium Labs ApS Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Hafnium Labs ApS Recent Developments and Future Plans
  • 2.14 XtalPi Inc
    • 2.14.1 XtalPi Inc Details
    • 2.14.2 XtalPi Inc Major Business
    • 2.14.3 XtalPi Inc Intelligent Drug R-D Services Product and Solutions
    • 2.14.4 XtalPi Inc Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 XtalPi Inc Recent Developments and Future Plans
  • 2.15 Schrödinger
    • 2.15.1 Schrödinger Details
    • 2.15.2 Schrödinger Major Business
    • 2.15.3 Schrödinger Intelligent Drug R-D Services Product and Solutions
    • 2.15.4 Schrödinger Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Schrödinger Recent Developments and Future Plans
  • 2.16 Charles River Laboratories
    • 2.16.1 Charles River Laboratories Details
    • 2.16.2 Charles River Laboratories Major Business
    • 2.16.3 Charles River Laboratories Intelligent Drug R-D Services Product and Solutions
    • 2.16.4 Charles River Laboratories Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.17 IQVIA Inc
    • 2.17.1 IQVIA Inc Details
    • 2.17.2 IQVIA Inc Major Business
    • 2.17.3 IQVIA Inc Intelligent Drug R-D Services Product and Solutions
    • 2.17.4 IQVIA Inc Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 IQVIA Inc Recent Developments and Future Plans
  • 2.18 Healx
    • 2.18.1 Healx Details
    • 2.18.2 Healx Major Business
    • 2.18.3 Healx Intelligent Drug R-D Services Product and Solutions
    • 2.18.4 Healx Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Healx Recent Developments and Future Plans
  • 2.19 Innoplexus
    • 2.19.1 Innoplexus Details
    • 2.19.2 Innoplexus Major Business
    • 2.19.3 Innoplexus Intelligent Drug R-D Services Product and Solutions
    • 2.19.4 Innoplexus Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Innoplexus Recent Developments and Future Plans
  • 2.20 EVAXION BIOTECH A/S
    • 2.20.1 EVAXION BIOTECH A/S Details
    • 2.20.2 EVAXION BIOTECH A/S Major Business
    • 2.20.3 EVAXION BIOTECH A/S Intelligent Drug R-D Services Product and Solutions
    • 2.20.4 EVAXION BIOTECH A/S Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 EVAXION BIOTECH A/S Recent Developments and Future Plans
  • 2.21 Icometrix
    • 2.21.1 Icometrix Details
    • 2.21.2 Icometrix Major Business
    • 2.21.3 Icometrix Intelligent Drug R-D Services Product and Solutions
    • 2.21.4 Icometrix Intelligent Drug R-D Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 Icometrix Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Intelligent Drug R-D Services Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Intelligent Drug R-D Services by Company Revenue
    • 3.2.2 Top 3 Intelligent Drug R-D Services Players Market Share in 2022
    • 3.2.3 Top 6 Intelligent Drug R-D Services Players Market Share in 2022
  • 3.3 Intelligent Drug R-D Services Market: Overall Company Footprint Analysis
    • 3.3.1 Intelligent Drug R-D Services Market: Region Footprint
    • 3.3.2 Intelligent Drug R-D Services Market: Company Product Type Footprint
    • 3.3.3 Intelligent Drug R-D Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Intelligent Drug R-D Services Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Intelligent Drug R-D Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Intelligent Drug R-D Services Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Intelligent Drug R-D Services Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Intelligent Drug R-D Services Consumption Value by Type (2018-2029)
  • 6.2 North America Intelligent Drug R-D Services Consumption Value by Application (2018-2029)
  • 6.3 North America Intelligent Drug R-D Services Market Size by Country
    • 6.3.1 North America Intelligent Drug R-D Services Consumption Value by Country (2018-2029)
    • 6.3.2 United States Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Intelligent Drug R-D Services Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Intelligent Drug R-D Services Consumption Value by Type (2018-2029)
  • 7.2 Europe Intelligent Drug R-D Services Consumption Value by Application (2018-2029)
  • 7.3 Europe Intelligent Drug R-D Services Market Size by Country
    • 7.3.1 Europe Intelligent Drug R-D Services Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 7.3.3 France Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Intelligent Drug R-D Services Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Intelligent Drug R-D Services Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Intelligent Drug R-D Services Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Intelligent Drug R-D Services Market Size by Region
    • 8.3.1 Asia-Pacific Intelligent Drug R-D Services Consumption Value by Region (2018-2029)
    • 8.3.2 China Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 8.3.5 India Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Intelligent Drug R-D Services Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Intelligent Drug R-D Services Consumption Value by Type (2018-2029)
  • 9.2 South America Intelligent Drug R-D Services Consumption Value by Application (2018-2029)
  • 9.3 South America Intelligent Drug R-D Services Market Size by Country
    • 9.3.1 South America Intelligent Drug R-D Services Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Intelligent Drug R-D Services Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Intelligent Drug R-D Services Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Intelligent Drug R-D Services Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Intelligent Drug R-D Services Market Size by Country
    • 10.3.1 Middle East & Africa Intelligent Drug R-D Services Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Intelligent Drug R-D Services Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Intelligent Drug R-D Services Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Intelligent Drug R-D Services Market Drivers
  • 11.2 Intelligent Drug R-D Services Market Restraints
  • 11.3 Intelligent Drug R-D Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Intelligent Drug R-D Services Industry Chain
  • 12.2 Intelligent Drug R-D Services Upstream Analysis
  • 12.3 Intelligent Drug R-D Services Midstream Analysis
  • 12.4 Intelligent Drug R-D Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Intelligent Drug R-D Services . Industry analysis & Market Report on Intelligent Drug R-D Services is a syndicated market report, published as Global Intelligent Drug R-D Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Intelligent Drug R-D Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,766.60
    		4,149.90
    		5,533.20
    		3,219.00
    		4,828.50
    		6,438.00
    		544,341.60
    		816,512.40
    		1,088,683.20
    		290,684.40
    		436,026.60
    		581,368.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo